SGP· Health Care› Biotechnology

SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. More about the company

$28.22

+1.84% today

$944M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is SGP early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2026-02-06 → 2026-10-22

S? 37w

2026-02-062026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 37w current

Total tracked: 37 weeks across 1 stage run.

SGP among Biotechnology572nd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…572	SGPSpyGlass Pharma, Inc.	—	—	+0.2%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 36

1w13w26w

Week 36, mature

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.87x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+0.2%

+37.7%

+19.4%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S—

Wk 36 · Vol 0.87x

2026-10-21S—

Wk 36 · Vol 0.82x

2026-10-20S—

Wk 36 · Vol 0.96x

2026-10-19S—

Wk 36 · Vol 0.67x

2026-10-16S—

Wk 35 · Vol 0.68x

2026-10-15S—

Wk 35 · Vol 0.45x

2026-10-14S—

Wk 35 · Vol 0.47x

2026-10-13S—

Wk 35 · Vol 0.60x

2026-10-12S—

Wk 35 · Vol 0.56x

2026-10-09S—

Wk 34 · Vol 0.64x

2026-10-08S—

Wk 34 · Vol 0.60x

2026-10-07S—

Wk 34 · Vol 0.65x

Moving averages & range

50 DMA

$26.62

200 DMA

—

52W High

—

52W Low

—

5D Low

$24.00

Resistance levels (recent highs)

20d High

$28.22

60d High

$29.33

120d High

$29.33

250d High

—

Next resistance

+3.9%

to 60d High

Dividend Yield

0.00%

P/B 4.1

SpyGlass Pharma: quick answers

Which sector and industry is SpyGlass Pharma in?

SpyGlass Pharma is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.